Is Codexis, Inc. (CDXS) a Buy, Sell, or Hold?
Codexis, Inc.
NASDAQ:CDXS
$2.21 USD
$0.08 (3.76%)
- Volume
- 491.84K
- Average Volume
- 1M
- Market Capitalization
- $200.88M
- P/E Ratio
- -6.04
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.87
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.36
| Source | Headline |
|---|---|
|
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-08 14:41:23 |
|
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates
Codexis (CDXS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.25 per share a year ago. zacks.com - 2026-05-07 20:11:38 |
|
Codexis Reports First Quarter 2026 Financial Results
Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance Three presentations at upcoming TIDES USA annual meeting to feature new data for ECO Synthesis manufacturing platform capabilities REDWOOD CITY, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the first quarter ended March 31, 2026, and provided a business update. globenewswire.com - 2026-05-07 16:05:00 |
|
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2026-04-30 11:06:27 |
|
Codexis to share RNA manufacturing advances at TIDES USA
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis® Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11–14 at the Hynes Convention Center in Boston. globenewswire.com - 2026-04-29 09:00:00 |
